Urethral Procedures with CC/MCC DRG

DRG 671 encompasses inpatient admissions for urethral procedures when a Complication or Comorbidity or Major Complication or Comorbidity is present, covering procedures such as urethral dilation, urethrotomy, and reconstructive operations. This Diagnosis-Related Group matters for inpatient reimbursement because the presence of Complication or Comorbidity or Major Complication or Comorbidity affects payment classification and resource intensity for Centers for Medicare & Medicaid Services hospital payments.

DRG 671 Overview

DRG 671 covers inpatient admissions for urethral procedures performed for a range of urologic conditions when a Complication or Comorbidity or Major Complication or Comorbidity is present. It includes operative interventions on the urethra such as dilations, urethrotomies, and reconstructive procedures associated with increased resource use. This Diagnosis-Related Group matters for Medicare payment because presence of Complication or Comorbidity or Major Complication or Comorbidity influences relative reimbursement and hospital case mix classification. Accurate clinical documentation and coding determine assignment to this Diagnosis-Related Group and thus the inpatient payment grouping.

Acute procedural optimization trials: studies comparing perioperative techniques and immediate postoperative protocols for patients undergoing urethral procedures complicated by comorbid conditions (for example, those with infection, bleeding risk, or acute urinary retention). These trials enroll inpatients scheduled for urethral dilation, endoscopic urethrotomy, or reconstruction with concomitant CC/MCC-level diagnoses to evaluate metrics such as procedural success, intraoperative complications, need for reintervention, and length of stay. Results inform care pathways and resource use, helping providers reduce complications and payers anticipate hospitalization costs tied to procedure-related adverse events and readmissions.
Comparative effectiveness studies of surgical approaches and device use in complex urethral disease: randomized or pragmatic cohort studies that compare different surgical techniques (open repair vs. endoscopic approaches) or adjunctive technologies (e.g., grafts, stents, or catheter strategies) in patients with significant comorbidities or secondary conditions recorded as CC/MCC. These studies focus on midterm outcomes such as stricture recurrence, functional urinary outcomes, complication rates, and need for additional inpatient stays, targeting populations such as older adults, patients with prior pelvic surgery, or those with infection/bleeding risks. Findings help clinicians select procedures that balance effectiveness and safety for high-risk inpatients, and help payers evaluate cost-effectiveness across approaches that drive DRG resource intensity.
Post-discharge outcomes and care coordination research: observational and interventional studies examining transitions of care, early outpatient follow-up, urinary catheter management, and prevention of readmission among patients discharged after urethral procedures who had CC/MCC-level complications. These investigations follow cohorts for 30–90 days to assess readmission drivers, wound or urinary tract infections, catheter-related problems, and patient-reported functional recovery, often testing care bundle interventions or enhanced discharge planning. This research is critical for providers to implement protocols that reduce complications and for payers to identify strategies that lower costly readmissions and post-acute care utilization associated with this DRG.

Acute procedural optimization trials: studies comparing perioperative techniques and immediate postoperative protocols for patients undergoing urethral procedures complicated by comorbid conditions (for example, those with infection, bleeding risk, or acute urinary retention). These trials enroll inpatients scheduled for urethral dilation, endoscopic urethrotomy, or reconstruction with concomitant CC/MCC-level diagnoses to evaluate metrics such as procedural success, intraoperative complications, need for reintervention, and length of stay. Results inform care pathways and resource use, helping providers reduce complications and payers anticipate hospitalization costs tied to procedure-related adverse events and readmissions.
Comparative effectiveness studies of surgical approaches and device use in complex urethral disease: randomized or pragmatic cohort studies that compare different surgical techniques (open repair vs. endoscopic approaches) or adjunctive technologies (e.g., grafts, stents, or catheter strategies) in patients with significant comorbidities or secondary conditions recorded as CC/MCC. These studies focus on midterm outcomes such as stricture recurrence, functional urinary outcomes, complication rates, and need for additional inpatient stays, targeting populations such as older adults, patients with prior pelvic surgery, or those with infection/bleeding risks. Findings help clinicians select procedures that balance effectiveness and safety for high-risk inpatients, and help payers evaluate cost-effectiveness across approaches that drive DRG resource intensity.
Post-discharge outcomes and care coordination research: observational and interventional studies examining transitions of care, early outpatient follow-up, urinary catheter management, and prevention of readmission among patients discharged after urethral procedures who had CC/MCC-level complications. These investigations follow cohorts for 30–90 days to assess readmission drivers, wound or urinary tract infections, catheter-related problems, and patient-reported functional recovery, often testing care bundle interventions or enhanced discharge planning. This research is critical for providers to implement protocols that reduce complications and for payers to identify strategies that lower costly readmissions and post-acute care utilization associated with this DRG.

OpenPayer

Summary & Overview

Urethral Procedures with CC/MCC: Inpatient Reimbursement Overview

DRG 671 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes